Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Multiple Sclerosis l: Introduction01:19

Multiple Sclerosis l: Introduction

20
Multiple sclerosis is a chronic autoimmune disease of the central nervous system (CNS) that affects the brain, spinal cord, and optic nerves. It is an inflammatory demyelinating disorder and a leading cause of neurological disability in young adults.EpidemiologyMS commonly begins between 20 and 40 years of age and is twice as common in women. Its exact cause remains unclear, but genetic susceptibility contributes, with higher risk in first-degree relatives and identical twins. A greater...
20
Depressive Disorders: MDD and Dysthymia01:27

Depressive Disorders: MDD and Dysthymia

1.3K
Depressive disorders are a group of mental health conditions characterized by pervasive feelings of sadness, diminished pleasure in life, and a significant impact on daily functioning. These conditions are most prevalent in individuals during their 30s and affect women at twice the rate of men. Contrary to popular belief, younger individuals are generally more susceptible to these disorders than older adults. Two key types of depressive disorders include Major Depressive Disorder (MDD) and...
1.3K
Depressive Disorders: Etiology01:27

Depressive Disorders: Etiology

884
Depressive disorders result from a complex interplay of biological, psychological, and sociocultural factors, each contributing uniquely to the development and persistence of the condition. Understanding these factors provides critical insight into the multifaceted nature of depression.
Biological Factors in Depression
Biological predispositions significantly influence the risk of developing depressive disorders. Genetic studies highlight the role of variations in the serotonin transporter...
884
Depression: Overview01:18

Depression: Overview

1.2K
Depression is a prevalent mental illness marked by persistent sadness and lack of interest in previously enjoyable activities. It can take several forms, including major depression, persistent depressive disorder, and bipolar I and II disorders. Symptoms range from emotional changes like chronic worry to physical changes like sleep disturbances and suicidal thoughts. From a neurobiological perspective, depression is believed to be triggered by abnormalities in the brain's prefrontal cortex,...
1.2K
Analgesia and Pain Management01:25

Analgesia and Pain Management

3.3K
Pain is critical to various clinical pathologies, provoking an urgent need for effective management. Pain, whether acute or chronic, is a complex neurochemical process. Its alleviation depends on the type, with nonopioid analgesics effective for mild to moderate pain, such as musculoskeletal or inflammatory pain, while neuropathic pain responds best to anticonvulsants, tricyclic antidepressants, or serotonin/norepinephrine reuptake inhibitors. For severe acute or chronic pain, opioids may be...
3.3K
Long-term Depression01:05

Long-term Depression

27.3K
Long-term depression, or LTD, is one of the ways by which synaptic plasticity—changes in the strength of chemical synapses—can occur in the brain. LTD is the process of synaptic weakening that occurs over time between pre and postsynaptic neuronal connections. The synaptic weakening of LTD works in opposition to synaptic strengthening by long-term potentiation (LTP) and together are the main mechanisms that underlie learning and memory.
27.3K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Exploring social moderators of telehealth treatment outcomes for adults with multiple sclerosis: A secondary analysis of a randomized controlled trial.

Rehabilitation psychology·2026
Same author

Examining state and trait resilience in individuals with spinal cord injury and chronic pain: A daily and longitudinal analysis.

Rehabilitation psychology·2026
Same author

Does Depressed Mood Affect Accuracy of Perceptions of Cognitive Function in Multiple Sclerosis? The Role of Momentary Depressive Symptoms in the Correspondence Between Subjective and Objective Cognition in Multiple Sclerosis.

Archives of physical medicine and rehabilitation·2026
Same author

Comparing Low and High Recovery Expectations Among Those with Lumbar Spinal Stenosis: A Network Analysis.

Pain medicine (Malden, Mass.)·2026
Same author

Examining the Impact of Perceived and Objective Cognitive Function on Social Participation in Individuals With Multiple Sclerosis.

Archives of physical medicine and rehabilitation·2026
Same author

Advancing consensus priorities for high-impact provider behaviors in multiple sclerosis care: A Delphi study.

Multiple sclerosis and related disorders·2026

Related Experiment Video

Updated: May 5, 2026

Burn Injury-Induced Pain and Depression-Like Behavior in Mice
07:08

Burn Injury-Induced Pain and Depression-Like Behavior in Mice

Published on: September 29, 2021

3.0K

Co-occurring depression and pain in multiple sclerosis.

Kevin N Alschuler1, Dawn M Ehde, Mark P Jensen

  • 1Department of Rehabilitation Medicine, University of Washington School of Medicine, Box 358815, 1536 North 115th Street, Seattle, WA 98133, USA.

Physical Medicine and Rehabilitation Clinics of North America
|December 10, 2013
PubMed
Summary

Depression and pain frequently co-occur in multiple sclerosis (MS) patients. This review explores their shared mechanisms, impact, and adapted treatment strategies for MS.

Keywords:
DepressionMultiple sclerosisPain

More Related Videos

Author Spotlight: Quantifying Pain Experience – An Illustrative Approach Using the Pain Body Diagram
09:00

Author Spotlight: Quantifying Pain Experience – An Illustrative Approach Using the Pain Body Diagram

Published on: July 7, 2023

5.2K
Spontaneous and Evoked Measures of Pain in Murine Models of Monoarticular Knee Pain
08:03

Spontaneous and Evoked Measures of Pain in Murine Models of Monoarticular Knee Pain

Published on: February 22, 2019

8.4K

Related Experiment Videos

Last Updated: May 5, 2026

Burn Injury-Induced Pain and Depression-Like Behavior in Mice
07:08

Burn Injury-Induced Pain and Depression-Like Behavior in Mice

Published on: September 29, 2021

3.0K
Author Spotlight: Quantifying Pain Experience – An Illustrative Approach Using the Pain Body Diagram
09:00

Author Spotlight: Quantifying Pain Experience – An Illustrative Approach Using the Pain Body Diagram

Published on: July 7, 2023

5.2K
Spontaneous and Evoked Measures of Pain in Murine Models of Monoarticular Knee Pain
08:03

Spontaneous and Evoked Measures of Pain in Murine Models of Monoarticular Knee Pain

Published on: February 22, 2019

8.4K

Area of Science:

  • Neuroscience
  • Clinical Psychology
  • Rehabilitation Medicine

Background:

  • Multiple sclerosis (MS) is a chronic neurological disease.
  • Depression and chronic pain are common comorbidities in MS.
  • These conditions often occur together, complicating patient management.

Purpose of the Study:

  • To review literature on the comorbidity of pain and depression in MS.
  • To describe the impact of co-occurring pain and depression on individuals with MS.
  • To discuss adaptations of current treatments for pain and depression in MS.

Main Methods:

  • Literature review and theoretical synthesis.
  • Analysis of existing research on pain and depression in MS.
  • Exploration of treatment strategies and shared mechanisms.

Main Results:

  • Pain and depression are highly prevalent and interconnected in MS.
  • Comorbidity significantly impacts quality of life and disease progression.
  • Shared biological and psychological mechanisms underlie both conditions.

Conclusions:

  • Understanding shared mechanisms is crucial for effective treatment.
  • Treatment adaptations are needed to address the complex interplay of pain and depression in MS.
  • Integrated approaches can improve outcomes for individuals with MS.